Source: Eur Respir J 2010; 35: 459
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hahn D.. Distinct clinical phenotypes of airways disease: a primary-care clinician perspective. Eur Respir J 2010; 35: 459

Member's Comments

No comment yet.

Related content which might interest you: Towards individualised medicine for airways disease: identifying clinical phenotype groups Source: Eur Respir J 2012; 39: 1033-1034 Year: 2012 A critical evaluation of the relevance of different asthma phenotypes for clinical practice Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 The disease model: implications for clinical practice Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018 Year: 2018 Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009 The future of treatment for interstitial lung diseases: the patient’s and physician’s perspective Source: International Congress 2019 – Rare lung diseases Year: 2019 Clinical asthma phenotypes in the real world: opportunities and challenges Source: Breathe 2015; 11:186-193 Year: 2015 Common pitfalls in the assessment of airway disease in primary care Source: Annual Congress 2009 - Controversies in the diagnosis of asthma Year: 2009 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice Source: Eur Respir J, 58 (3) 2100627; 10.1183/13993003.00627-2021 Year: 2021 Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers Source: Eur Respir J, 55 (5) 2001028; 10.1183/13993003.01028-2020 Year: 2020 Change in patients asthma control: Possible bias of transition ratings in clinical practice Source: Eur Respir J 2003; 22: Suppl. 45, 12s Year: 2003 Integrating patients with respiratory and cardiac disease in one rehabilitation programme: clinical outcomes of a pragmatic service evaluation. Source: International Congress 2019 – Innovations in care for chronic respiratory conditions Year: 2019 Progressive respiratory disease: the importance of prognostic conversations and advance care planning Source: Breathe, 13 (4) 269; 10.1183/20734735.012917 Year: 2017 Contemporary challenges for specialist nursing in interstitial lung disease Source: Breathe, 14 (1) 36; 10.1183/20734735.014917 Year: 2018 Making clinical sense of phenotypes and endotypes of COPD Source: ERS Course 2019 - Masterclass in airways disease 2019 Year: 2019 Confronting asthma and COPD: the toolkit of the advanced nurse practitioner Source: Eur Respir J 2003; 22: Suppl. 45, 511s Year: 2003 Biomarker development in asthma from a patient's perspective Source: Breathe, 15 (4) 277; 10.1183/20734735.0303-2019 Year: 2019 Impact of a spirometry expert system on general practitioners‘ decision-making when diagnosing chronic respiratory disease: a cluster-randomised trial Source: Annual Congress 2007 - Managing COPD in primary care Year: 2007 Omics in population studies: a molecular epidemiology perspective in chronic airway disease Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome Year: 2014 Biomarkers of airways inflammation in patients with severe asthma in a real clinical practice Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019